Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,253.06
    +4.57 (+0.09%)
     
  • Dow

    39,754.63
    -5.45 (-0.01%)
     
  • Nasdaq

    16,403.99
    +4.47 (+0.03%)
     
  • Bitcoin USD

    71,346.88
    +1,666.66 (+2.39%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,966.24
    +34.26 (+0.43%)
     
  • Gold

    2,233.10
    +20.40 (+0.92%)
     
  • Crude Oil

    82.43
    +1.08 (+1.33%)
     
  • 10-Yr Bond

    4.2040
    +0.0080 (+0.19%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

IBM and Brinker are big market movers

Brinker, IBM, Norfolk Southern, FirstEnergy and Nuance are big market movers

NEW YORK (AP) -- Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:

NYSE

IBM Corp., down $6.18 to $182.25

Light fourth-quarter revenue revealed the thin margins the tech company is working with as it shifts from hardware to software and services.

Coach Inc., down $3.17 to $49.38

Rivals including Michael Kors and Vera Bradley are cutting into the luxury-goods merchant's market share.

Brinker International Inc., up $3.03 to $49.72

The parent company of Chili's and Maggiano's restaurants reported a 7 percent jump in quarterly profit as menu prices rose.

ADVERTISEMENT

Norfolk Southern Corp., up $4.23 to $92.94

The railroad's fourth-quarter profit jumped 24 percent as deliveries of other goods more than offset continued weak coal demand.

FirstEnergy Corp., down $1.02 to $31.13

With energy prices and sales falling, the utility cut its dividend for the first time its 17-year history.

Nasdaq

AMAG Pharmaceuticals Inc., down 99 cents to $20.87

Federal regulators reject the specialty drugmaker's appeal for the expanded use of its anemia treatment, Feraheme.

Nuance Communications Inc., up $1.16 to $16.05

The voice technology company boosted its quarterly forecast after struggling for the past year with internal and external factors.

Keryx Biopharmaceuticals Inc., down 78 cents to $14.60

The biopharmaceutical company opened a $90 million underwritten public offering of common shares.